References
- Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020–1025.
- McCartney CR, Marshall JC, Clinical P. Polycystic ovary syndrome. N Engl J Med. 2016;375(1):54–64.
- Benson S, Arck PC, Tan S, et al. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009;34(5):727–735.
- Gambineri A, Fanelli F, Tomassoni F, et al. Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls. Eur J Endocrinol. 2014;171(1):47–57.
- Qi J, Wang W, Zhu Q, et al. Local cortisol elevation contributes to endometrial insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(7):2457–2467.
- Zhu Q, Zuo R, He Y, et al. Local regeneration of cortisol by 11beta-HSD1 contributes to insulin resistance of the granulosa cells in PCOS. J Clin Endocrinol Metab. 2016;101(5):2168–2177.
- Wang W, Chen ZJ, Myatt L, et al. 11beta-HSD1 in human fetal membranes as a potential therapeutic target for preterm birth. Endocr Rev. 2018;39(3):241–260.
- Michael AE, Thurston LM, Rae MT. Glucocorticoid metabolism and reproduction: a tale of two enzymes. Reproduction. 2003;126(4):425–441.
- Yong PY, Harlow C, Thong KJ, et al. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1. Hum Reprod. 2002;17(9):2300–2306.
- Michael AE, Evagelatou M, Norgate DP, et al. Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol. 1997;132(1–2):43–52.
- Itoi S, Terao M, Murota H, et al. 11beta-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes. Biochem Biophys Res Commun. 2013;440(2):265–270.
- Zhang C, Ma J, Wang W, et al. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome. Hum Reprod. 2018;33(11):2096–2106.
- Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2–13.
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
- Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25(5):831–866.
- Whirledge S, Cidlowski JA. Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction. Trends Endocrinol Metab. 2017;28(6):399–415.
- Prasad SM, Tiwari AN, Pandey TG, et al. Impact of stress on oocyte quality and reproductive outcome. J Biomed Sci. 2016;23(1):36.
- Yuan XH, Yang BQ, Hu Y, et al. Dexamethasone altered steroidogenesis and changed redox status of granulosa cells. Endocrine. 2014;47(2):639–647.
- Yang Z, Guo C, Zhu P, et al. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts. J Endocrinol. 2007;195(2):241–253.
- Yang Z, Zhu X, Guo C, et al. Stimulation of 11beta-HSD1 expression by IL-1beta via a C/EBP binding site in human fetal lung fibroblasts. Endocr. 2009;36(3):404–411.